Evidence map›Paper›PMID 33462322›Full record

ArticleScientific reports2021

Usability assessment of drug-linking laboratory data listed on prescriptions for outpatients of chiba university hospital.

Iichiro Yokoyama, Hiroki Yamaguchi, Kaori Yamazaki, Misato Sekiya, Sayaka Arai, Takako Nakamura, Takaaki Suzuki, Itsuko Ishii

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Iichiro YokoyamaDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan. i.yokoyama@chiba-u.jp.
Hiroki YamaguchiDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Kaori YamazakiDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Misato SekiyaDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Sayaka AraiDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Takako NakamuraDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Takaaki SuzukiDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.
Itsuko IshiiDivision of Pharmacy, Chiba University Hospital, 1-8-1 Inohana, Chuo-ku Chiba-shi, Chiba, 260-8677, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To evaluate the impact of pharmacotherapy on efficacy and safety by providing laboratory data information linked to medicines on outpatient prescriptions from the hospital to the community pharmacy. Beginning on October 28, 2014, standardized laboratory data and drug-linking laboratory data were included with outpatient prescriptions at our hospital. We have created a database of drug-linking laboratory data for all drugs that can be prescribed in Japan. We counted the number of prescription inquiries related to laboratory data from community pharmacies, including those leading to prescription changes. Before laboratory data were listed on outpatient prescriptions, 4 prescription inquiries from community pharmacies per year were related to laboratory data. After our hospital started to list laboratory data, this number rose to 643, 576, 563, and 847 in the first, second, third, and fourth year (P < .05). Of these, 132, 143, 152, and 224 inquiries resulted in prescription changes. Listing laboratory data on outpatient prescriptions avoided 153 contraindications and 84 exacerbations of adverse drug reactions in four years by a prescription inquiry that had never been done before. The efficacy and safety of pharmacotherapy can be improved by listing relevant laboratory data on outpatient prescriptions.

Identifiers

PMID33462322
PMCPMC7814059

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.